![]() |
市場調查報告書
商品編碼
1392329
全球灌注系統市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢和預測Global Perfusion System Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
全球灌注系統市場需求預計將從 2022 年的 42.4 億美元達到 2030 年近 76.8 億美元的市場規模,2023-2030 年研究期間CAGR為 6.82%。
灌注系統是用於在手術期間將含氧血液輸送到身體的裝置。灌注系統用於心臟手術,灌注專家透過使用人工血泵向患者註入血液,在心臟外科醫生手術時取代心臟的功能。灌注系統也用於化療,以治療手臂或腿部的黑色素瘤。灌注系統技術暫時停止肢體中的血流,將抗癌藥物直接注射到肢體的血液中。器官移植手術使用灌注系統,因為它們透過將血液泵送到全身來幫助在手術過程中替代器官的功能。
隨著全球心血管和呼吸系統疾病盛行率的不斷上升,全球灌注系統市場可能會成長。此外,飲食不當、吸煙和飲酒也會導致器官衰竭,這導致了對有效灌注系統的需求。此外,灌注系統市場也受到製藥和生物技術產業顯著成長的推動。此外,技術發展為未來幾年的市場成長提供了重大機會。然而,發展中國家對灌注系統缺乏認知可能會限制該市場的成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球灌注系統市場的各個細分市場進行了包容性評估。灌注系統產業的成長和趨勢為本研究提供了整體方法。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲灌注系統市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。灌注系統市場的主要參與者包括 Getinge AB、Medtronic plc、LivaNova、Terumo Corporation、Nipro Corporation、XENIOS AG、Repligen Corporation、Spectrum Laboratories Inc.、Merck KGaA、Harvard Bioscience Inc.、ALA Scientific Instruments, Inc.、Lifeline科學公司、XVIVO 灌注公司。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Perfusion System Market is presumed to reach the market size of nearly USD 7.68 BN by 2030 from USD 4.24 BN in 2022 with a CAGR of 6.82% under the study period 2023 - 2030.
Perfusion system is a device used to deliver oxygenated blood to the body during surgery. Perfusion systems are used in heart surgeries where perfusion experts thrust patients' blood by employing artificial blood pumps, which replace the heart's function while the cardiac surgeon operates. Perfusion systems are also used in chemotherapy for the treatment of melanoma present in the arm or legs. Perfusion system technique temporarily stops blood flow in the limb, allowing anticancer drugs to be injected directly into the limb's blood. Organ transplant surgeries use perfusion systems as they help replace the organ's function during the operation by pumping blood throughout the body.
The global perfusion system market is likely to grow with the increasing prevalence of cardiovascular and respiratory diseases across the globe. Moreover, improper diet, smoking and consumption of alcohol also leads to organ failure, which has led to the demand for effective perfusion systems. Furthermore, the perfusion systems market is also driven by the significant growth of the pharmaceutical and biotechnology industries. Additionally, technological development holds a significant opportunity for market growth in the coming years. However, a lack of awareness regarding perfusion systems in developing countries can limit the growth of this market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of perfusion system. The growth and trends of perfusion system industry provide a holistic approach to this study.
This section of the perfusion system market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Perfusion System market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Perfusion System market include Getinge AB, Medtronic plc, LivaNova, Terumo Corporation, Nipro Corporation, XENIOS AG, Repligen Corporation, Spectrum Laboratories Inc., Merck KGaA, Harvard Bioscience Inc., ALA Scientific Instruments, Inc., Lifeline Scientific Inc, XVIVO Perfusion AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.